@article{article, title  = {{Efficacy and safety of oral semaglutide in patients with type 2 diabetes and moderate renal impairment (PIONEER 5): a placebo-controlled, randomised, phase 3a trial}},

 publisher = {{Elsevier BV}},

 url = {{}},

 year = {{2019}},

 month = {{7}},

 author = {{Mosenzon O and Blicher TM and Rosenlund S and Eriksson JW and Heller S and Hels OH and Pratley R and Sathyapalan T and Desouza C and Abramof R and Alpenidze D et al}},

 doi = {{10.1016/s2213-8587(19)30192-5}},

 volume = {{7}},

 journal = {{The Lancet Diabetes & Endocrinology}},

 issue = {{7}},

 pages = {{515-527}},

 note = {{Accessed on 2024/10/22}}}